ZIMMER BIOMET HOLDINGS, INC. Restructuring and Related Cost, Expected Number of Positions Eliminated
ZIMMER BIOMET HOLDINGS, INC. (ZBH) reported Restructuring and Related Cost, Expected Number of Positions Eliminated of 500 Person for the 9-month period ending 2011-09-30, per its 10-Q filed 2011-11-02.
Discontinued › Expense Statement › Operating Expenses
us-gaap:RestructuringAndRelatedCostExpectedNumberOfPositionsEliminated · last filed 2011-11-02
- 2011-09-30: Restructuring and Related Cost, Expected Number of Positions Eliminated 9 month 500.00 Person.
Person
| Period end | Restructuring and Related Cost, Expected Number of Positions Eliminated 9 month |
|---|---|
| 2011-09-30 | 500.00 Person 10-Q · filed 2011-11-02 |
pure
| Period end | Restructuring and Related Cost, Expected Number of Positions Eliminated 6 month |
|---|---|
| 2011-06-30 | 50000.00% 10-Q · filed 2011-08-08 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| STERIS plc (STE) | Ireland | $20.343B | 25.49 |
| ALIGN TECHNOLOGY INC (ALGN) | United States | $10.346B | 29.06 |
| MSA Safety Inc (MSA) | United States | $7.023B | 21.47 |
| ESTABLISHMENT LABS HOLDINGS INC. (ESTA) | $1.954B | -65.76 | |
| Cadre Holdings, Inc. (CDRE) | United States | $1.123B | 33.88 |
| Enovis CORP (ENOV) | United States | $1.053B | -1.18 |
| Anteris Technologies Global Corp. (AVR) | United States | $0.746B | |
| Sanara MedTech Inc. (SMTI) | United States | $0.323B | -6.81 |
| Inogen Inc (INGN) | United States | $0.139B | -7.00 |
| Conexeu Sciences Inc. (CNXU) | United States | $0.111B |